Updated:
Health Enterprise Partners
Health Enterprise Partners was founded in 2006 by Dave Tamburri, Ezra Mehlman, and Rick Stowe, combining private equity discipline with the purchasing...
Health Enterprise Partners
Health Enterprise Partners was founded in 2006 by Dave Tamburri, Ezra Mehlman, and Rick Stowe, combining private equity discipline with the purchasing power and strategic insight of the nation's largest healthcare organizations. The firm operates against an explicit thesis: that technology and services companies selling into the hospital and payer ecosystem need more than money — they need distribution. HEP organizes its investor base as a strategic network, with limited partners that hold senior roles at leading hospital systems, forming what the firm calls a 'Hospital Advisory Network' to validate products and accelerate sales cycles for its portfolio companies. Strategy is concentrated on growth-stage and expansion-stage healthcare services and healthcare information technology. Asset classes in scope include direct equity investments across healthcare IT, tech-enabled services, and outsourced provider services. The firm avoids biotechnology and pharmaceuticals, preferring companies that apply technology or business-process innovation to reduce cost, improve outcomes, or increase patient access. Portfolio investments have historically run from roughly $15 million to $40 million per transaction, targeting minority and majority recapitalizations. Geographic focus is overwhelmingly domestic, concentrated in the United States, though select portfolio companies serve global health systems. Confirmed investments include AbleTo, a behavioral health telehealth platform that was acquired by UnitedHealth Group's Optum, and Vitals, a transparency and consumer engagement platform that was acquired by WebMD. Team size and current AUM are not publicly disclosed. The firm maintains its headquarters in New York and has not opened satellite offices. HEP does not operate a separate philanthropic vehicle, but it does run a formal operator-in-residence program that embeds experienced health system executives with portfolio companies. Recent verifiable activity includes a leadership transition to the current managing partner group of Tamburri and Mehlman as the day-to-day investment leads, with Stowe moving to a senior advisor role. What distinguishes HEP from generic healthcare private equity is its structural integration of a hospital-advisor network within the fund itself. This is not a side advisory board — it is a formalized system embedded in the due diligence and post-investment operating model, giving HEP a sourcing and validation mechanism that generalist funds cannot replicate. The model resembles a captive strategic channel more than a sponsor-only vehicle, making it particularly relevant for founders whose exit strategy depends on enterprise adoption by large integrated delivery networks.
General information
Firm type
Private Equity
Year founded
2006
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Dave Tamburri
Managing Partner
Ezra Mehlman
Managing Partner
Rick Stowe
Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Health Enterprise Partners?
Dave Tamburri and Ezra Mehlman lead the firm as Managing Partners and sit on the Investment Committee. Rick Stowe, a co-founder, remains involved as a Senior Advisor. The managing partners handle day-to-day sourcing, diligence, and portfolio management.
How does HEP source proprietary deal flow?
HEP maintains a formal Hospital Advisory Network composed of its limited partners — senior executives at major hospital systems and health plans across the United States. This network surfaces market needs, validates portfolio company products in live clinical and operational environments, and often introduces the firm to founder-led businesses that are pre-revenue or early-commercial but already solving a real health-system pain point.
Does HEP participate in fund commitments or only direct deals?
HEP makes direct equity investments and structures recapitalizations, typically writing checks between $15 million and $40 million. The firm does not market a fund-of-funds strategy and has not publicly disclosed commitments to external private equity managers. Its mandate is concentrated on building a portfolio of company-level positions.
What investment stages does HEP typically target?
Health Enterprise Partners invests at the growth and expansion stage. Companies typically have validated products and initial commercial traction with health systems or payers. HEP structures both minority and majority recapitalizations and does not compete for seed or early-venture rounds where the commercial use case is still theoretical.
Which sectors does Health Enterprise Partners explicitly avoid?
The firm stays out of biotechnology, pharmaceuticals, and medical devices that require FDA pre-market approval. It concentrates strictly on healthcare information technology, tech-enabled services, and outsourced provider services that deliver near-term return on investment for payer and provider organizations.
How is HEP's limited partner base structured, and why does it matter?
HEP's limited partner base includes some of the largest not-for-profit hospital systems and health plans in the United States. Rather than treating these LPs as passive capital, HEP integrates them into its Hospital Advisory Network — a formal mechanism that allows portfolio companies to pilot solutions, gain reference accounts, and accelerate enterprise sales within a network that controls substantial healthcare purchasing power.
Does the firm maintain any operating executive programs for portfolio companies?
Yes. HEP runs an operator-in-residence program that places experienced health system and payer executives into portfolio companies. These operators work alongside founders to refine go-to-market strategy and build the commercialization infrastructure needed to sell into large integrated delivery networks.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: